NCT04190667 |
|
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
|
View
|
NCT01331018 |
|
Gene Therapy for Fanconi Anemia
|
View
|
NCT03351868 |
|
FANCA Gene Transfer for Fanconi Anemia Using a High-safety High-efficiency Self-inactivating Lentiviral Vector
|
View
|
NCT04248439 |
|
Gene Therapy for Fanconi Anemia Complementation Group A
|
View
|
NCT04508803 |
|
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
|
View
|
NCT04437771 |
|
Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy
|
View
|
NCT03012321 |
|
AbirateronePrednisone Olaparib or AbirateronePrednisone Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
|
View
|
NCT03157804 |
|
Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A
|
View
|
NCT06392841 |
|
Niraparib Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations
|
View
|
NCT04069533 |
|
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
|
View
|
NCT02931071 |
|
Clinical Phase II Trial to Evaluate CD34 Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene FANCOSTEM-1
|
View
|
NCT05787587 |
|
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
|
View
|
NCT03814408 |
|
A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A
|
View
|
NCT04171700 |
|
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
|
View
|
NCT02952534 |
|
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
|
View
|